HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diego Alves Selected Research

7-chloro-4-(phenylselanyl) quinoline

10/20227-Chloro-4-(Phenylselanyl) Quinoline Is a Novel Multitarget Therapy to Combat Peripheral Neuropathy and Comorbidities Induced by Paclitaxel in Mice.
3/2022Interface of Aging and Acute Peripheral Neuropathy Induced by Oxaliplatin in Mice: Target-Directed Approaches for Na+, K+-ATPase, Oxidative Stress, and 7-Chloro-4-(phenylselanyl) quinoline Therapy.
7/2021The neurotherapeutic role of a selenium-functionalized quinoline in hypothalamic obese rats.
12/2020Advances in the Understanding of Oxaliplatin-Induced Peripheral Neuropathy in Mice: 7-Chloro-4-(Phenylselanyl) Quinoline as a Promising Therapeutic Agent.
1/2020Pharmacological modulation of Na+, K+-ATPase as a potential target for OXA-induced neurotoxicity: Correlation between anxiety and cognitive decline and beneficial effects of 7-chloro-4-(phenylselanyl) quinoline.
9/20197-Chloro-4-(Phenylselanyl) Quinoline with Memory Enhancer Action in Aging Rats: Modulation of Neuroplasticity, Acetylcholinesterase Activity, and Cholesterol Levels.
9/2018Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer's disease model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Diego Alves Research Topics

Disease

9Alzheimer Disease (Alzheimer's Disease)
06/2023 - 09/2018
7Neuroinflammatory Diseases
04/2023 - 01/2019
5Pain (Aches)
03/2022 - 01/2007
4Memory Disorders (Memory Loss)
01/2022 - 01/2019
4Cognitive Dysfunction
01/2022 - 09/2019
3Peripheral Nervous System Diseases (PNS Diseases)
10/2022 - 12/2020
3Inflammation (Inflammations)
01/2022 - 01/2019
3Edema (Dropsy)
02/2020 - 06/2016
3Hyperalgesia
01/2019 - 09/2012
3Depressive Disorder (Melancholia)
01/2018 - 07/2012
2Major Depressive Disorder (Major Depressive Disorders)
01/2023 - 11/2021
2Obesity
09/2021 - 07/2021
1Paralysis (Palsy)
06/2023
1Mental Disorders (Mental Disorder)
01/2023
1Dementia (Dementias)
01/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2022
1Neurobehavioral Manifestations
07/2021
1COVID-19
06/2021
1Amnesia (Dissociative Amnesia)
01/2020
1Parkinson Disease (Parkinson's Disease)
07/2019
1Mitochondrial Diseases (Mitochondrial Disease)
05/2019
1Amyloid Plaque
01/2019
1Atopic Dermatitis (Atopic Eczema)
03/2018
1Chronic Pain
01/2018
1Ulcer
11/2017
1Pleurisy (Pleuritis)
10/2017
1Trichomonas Infections
05/2017
1Infections
05/2017
1Mania (Manias)
01/2017

Drug/Important Bio-Agent (IBA)

77-chloro-4-(phenylselanyl) quinolineIBA
10/2022 - 09/2018
6Antidepressive Agents (Antidepressants)IBA
04/2023 - 07/2012
6AntioxidantsIBA
10/2022 - 05/2008
5QTC-4-MeOBnEIBA
03/2023 - 01/2019
5AcetylcholinesteraseIBA
03/2023 - 07/2019
4Adenosine Triphosphatases (ATPase)IBA
03/2022 - 01/2020
4Cholinergic Agents (Cholinergics)IBA
01/2021 - 01/2019
3Peptides (Polypeptides)IBA
06/2023 - 09/2018
3Amyloid Precursor Protein Secretases (beta-Secretase)IBA
03/2023 - 04/2022
3Glycogen Synthase KinasesIBA
03/2023 - 04/2022
3Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2022 - 01/2020
3Streptozocin (Streptozotocin)FDA Link
11/2021 - 01/2019
3Croton OilIBA
02/2020 - 06/2016
3acetophenoneIBA
01/2019 - 01/2018
2LigandsIBA
03/2023 - 04/2022
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2023 - 10/2022
2purineIBA
03/2023 - 01/2021
2EnzymesIBA
10/2022 - 12/2020
2Superoxide DismutaseIBA
03/2022 - 12/2020
2Glutathione PeroxidaseIBA
03/2022 - 12/2020
2LipopolysaccharidesIBA
01/2022 - 01/2019
2Sodium Glutamate (Accent)IBA
09/2021 - 07/2021
2SeleniumIBA
01/2021 - 09/2012
2Glutamic Acid (Glutamate)FDA Link
02/2020 - 01/2007
2Formaldehyde (Formol)FDA Link
02/2020 - 06/2016
2Acetic Acid (Vinegar)FDA LinkGeneric
02/2020 - 01/2007
2Scopolamine (Hyoscine)FDA Link
01/2020 - 01/2020
2quinolineIBA
01/2020 - 03/2018
2Peroxidase (Myeloperoxidase)IBA
11/2017 - 06/2016
2diphenyldiselenideIBA
09/2012 - 01/2007
1NanocapsulesIBA
06/2023
1Interleukin-4 (Interleukin 4)IBA
04/2023
1InterferonsIBA
03/2023
1Glial Fibrillary Acidic ProteinIBA
03/2023
1CytokinesIBA
03/2023
1Amyloid beta-PeptidesIBA
01/2023
1Paclitaxel (Taxol)FDA LinkGeneric
10/2022
1Interleukin-1beta (Interleukin 1 beta)IBA
10/2022
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2022
1CalciumIBA
10/2022
1NF-kappa B (NF-kB)IBA
10/2022
1Messenger RNA (mRNA)IBA
10/2022
1NitritesIBA
03/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022
1NitratesIBA
03/2022
1Freund's AdjuvantIBA
01/2022
1Pentylenetetrazole (Metrazol)IBA
01/2022
1acetoacetic acid (acetoacetate)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1(octylseleno)-xylofuranosideIBA
11/2021
1Antiviral Agents (Antivirals)IBA
06/2021
1CatalaseIBA
12/2020
1SodiumIBA
02/2020
1CholesterolIBA
09/2019
1Anti-Anxiety Agents (Anxiolytics)IBA
01/2019
1EndotoxinsIBA
01/2019
1Amyloid (Amyloid Fibrils)IBA
09/2018
1Reserpine (Serpasil)FDA Link
01/2018
1Analgesics (Analgesic Drugs)IBA
01/2018
1Monoamine Oxidase (MAO)IBA
01/2018
1Meloxicam (Mobic)FDA LinkGeneric
11/2017
17-chloro-4-phenylsulfonyl quinolineIBA
11/2017
1CarrageenanIBA
10/2017
1Metronidazole (Metric)FDA LinkGeneric
05/2017
1Ouabain (G Strophanthin)IBA
01/2017
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2013
1Therapeutic UsesIBA
09/2012
1Gabapentin (Neurontin)FDA LinkGeneric
09/2012

Therapy/Procedure

4Therapeutics
10/2022 - 07/2021
2Injections
01/2022 - 09/2021
1Intranasal Administration
04/2023